14 Years Manufacturer Curcuma Longa Extract Factory from Mali
14 Years Manufacturer Curcuma Longa Extract Factory from Mali Detail:
[Latin Name] Curcuma longa L.
[Plant Source] Root From India
[Specification] Curcuminoids 95% HPLC
[Appearance] Yellow powder
Plant Part Used: Root
[Particle size]80Mesh
[Loss on drying] ≤5.0%
[Heavy Metal] ≤10PPM
[Storage] Store in cool & dry area, keep away from the direct light and heat.
[Shelf life] 24 Months
[Package] Packed in paper-drums and two plastic-bags inside.
[Net weight] 25kgs/drum
[What is Curcuma Longa?]
Turmeric is an herbaceous plant known scientifically as Curcuma longa. It belongs to the Zingiberaceae family, which includes ginger. Tumeric has rhizomes rather than true roots, which are the primary source of commercial value for this plant. Tumeric originates from southwest India, where it has been a stable of Siddha medicine for thousands of years. It is also a common spice in Indian cuisine and is often used as flavoring for Asian mustards.
Product detail pictures:
Related Product Guide:
Using a total scientific good quality management process, superior high quality and excellent faith, we get great name and occupied this field for 14 Years Manufacturer Curcuma Longa Extract Factory from Mali , The product will supply to all over the world, such as: Boston, United Kingdom, Cannes, To meet the requirements of individual customers for each bit more perfect service and stable quality products. We warmly welcome customers around the world to visit us, with our multi-faceted cooperation, and jointly develop new markets, create a brilliant future!
In this Grand Rounds, UW Medicine physician, Dr. Elizabeth Dailey discusses the definition of outcomes research and its historical and contemporary contexts. Dr. Michael Lee, assistant professor with UW Medicine, then discusses the significance of orthopaedic complications and how the nature of complications has a large impact on outcomes. Through the use of a case study, Dr. Lee shows the challenging nature of guiding our patients through complications and what the implications are on their health care costs. Finally, the doctors discuss the difficult topic of which outcomes to use in our patient populations and what this means for health care policy. Dr. Darin Davidson, Assistant Professor of Oncology with UW Medicine, draws from his extensive outcomes research background in sarcoma patients to describe and explain quality of life, then uses this premise to guide us through clinical decision-making in a case study using quality of life as a guiding principle.
Dr. Pansak explains more about Pycnogenol
This supplier stick to the principle of "Quality first, Honesty as base", it is absolutely to be trust.

